Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.

Antiviral therapy - 1 Jan 2017

Paolucci Stefania, Premoli Marta, Ludovisi Serena, Mondelli Mario U, Baldanti Fausto

Abstract excerpt

Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Drug Combinations
Share to Liver Cirrhosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Reassortant Viruses

Share to Ribavirin

Share to Sequence Analysis, RNA

Share to Sofosbuvir

Share to Treatment Failure

Source

Identifiers

PMID: 28085002
DOI: 10.3851/IMP3130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy.PMID 28085002Read ↗

Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals.Semantic proximity Read ↗

Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment.Semantic proximity Read ↗

High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatmentSemantic proximity Read ↗

DAA Treatment Failure in a HIV/HBV/HCV Co-Infected Patient Carrying a Chimeric HCV Genotype 4/1b.Semantic proximity Read ↗

HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.Semantic proximity Read ↗

Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in UzbekistanSemantic proximity Read ↗

Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCR.Semantic proximity Read ↗

Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed Hepatitis C infection: a case report.Semantic proximity Read ↗

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.Semantic proximity Read ↗

Naturally occurring genotype 2b/1a hepatitis C virus in the United States.Semantic proximity Read ↗

Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.Semantic proximity Read ↗

Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.